SEC Filing Details

SEC Filing Details

Document Details

Form
3
Filing Date
January 03, 2023
Document Date
January 01, 2023
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
VBL Therapeutics
Issuer
Vascular Biogenics Ltd.
Filer
BEN ZVI SHMUEL